Pfizer 4Q Revenue Beats; Merck’s Forecast Misses Expectations; PepsiCo Pledging to Cut Some Prices

Pfizer 4Q Revenue Beats; Merck’s Forecast Misses Expectations; PepsiCo Pledging to Cut Some Prices

Today's biggest winners and losers in the stock market.


On this episode of Stock Movers:
- Pfizer (PFE) reported revenue for the fourth quarter that beat the average analyst estimate.
- Merck (MRK) forecast 2026 sales and profit that missed Wall Street’s expectations as continued challenges with its HPV vaccine Gardasil, which may remain off the market in China this year, overshadowed growth from newer drugs. Full-year sales will be $65.5 billion to $67 billion, Merck said Tuesday, below the average estimate from analysts. The company expects adjusted earnings of as much as $5.15 a share. The stock fell as much as 3.2% in pre-market trading.
- Snacks and beverage company PepsiCo (PEP) reported better-than-expected fourth-quarter profit, buoyed by strong international demand, and announced a $10 billion share buyback.New York-based PepsiCo, which owns brands such as Lay’s and Gatorade, posted earnings per share of $2.26, slightly ahead of Wall Street estimates.

See omnystudio.com/listener for privacy information.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(2276)

Netflix Drops, Carvana Climbs, P&G Rises on Assurance US Sales Are Bouncing Back

Netflix Drops, Carvana Climbs, P&G Rises on Assurance US Sales Are Bouncing Back

On this episode of Stock Movers:- Netflix (NFLX) shares drop after Paramount Skydance files a preliminary proxy materials with the SEC to solicit Warner Bros. Discovery holders to vote against the ame...

22 Jan 4min

Corcept Therapeutic Soars, Abbott Labs Sinks, Arista Networks Jumps on AI Spending

Corcept Therapeutic Soars, Abbott Labs Sinks, Arista Networks Jumps on AI Spending

On this episode of Stock Movers:- Corcept Therapeutic (CORT) shares soar after the pharmaceutical firm said its Phase 3 ROSELLA trial of relacorilant plus nab-paclitaxel in platinum-resistant ovarian ...

22 Jan 3min

Intel Shares Climb; P&G Growth Stalls; Paramount Extends Tender Offer For WBD

Intel Shares Climb; P&G Growth Stalls; Paramount Extends Tender Offer For WBD

On this episode of Stock Movers:- Intel (INTC) shares jumped as much as 12% on Wednesday to the highest since January 2022 amid a broad rally in semiconductor stocks after Nvidia CEO Jensen Huang talk...

22 Jan 4min

Beazley Dips, B&M Rises, Telenor Down

Beazley Dips, B&M Rises, Telenor Down

On this episode of Stock Movers:- Beazley shares fall as much as 7% before paring losses after the Lloyd’s of London insurer’s board unanimously rejects a cash proposal of 1,280p per share from Zurich...

22 Jan 4min

VW Rebounds, B&M Drops, Ubisoft Slips

VW Rebounds, B&M Drops, Ubisoft Slips

On this episode of Stock Movers:- Volkswagen ended 2025 with more cash in its automotive division than forecast as the German carmaker delays projects and investments in an overhaul of its electric-ve...

22 Jan 4min

Johnson & Johnson Drops, Kraft Heinz Declines, Nathan's Famous Surges

Johnson & Johnson Drops, Kraft Heinz Declines, Nathan's Famous Surges

On this episode of Stock Movers:- Johnson & Johnson (JNJ) shares drop as much as 3.1% in premarket trading after the health-care company reported mixed drug sales for the fourth quarter. The firm also...

21 Jan 4min

Closing Bell: Moderna and Nathan's Surges, Kraft Heinz Declines on Berkshire Sale

Closing Bell: Moderna and Nathan's Surges, Kraft Heinz Declines on Berkshire Sale

On this episode of Stock Movers:Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greif...

21 Jan 5min

Netflix Disappoints, Charles Schwab Surges, United Airlines Rises

Netflix Disappoints, Charles Schwab Surges, United Airlines Rises

On this episode of Stock Movers:-Netflix (NFLX) gave a disappointing forecast for earnings in the months ahead as it spends more on programming and works to close its $82.7 billion deal with Warner Br...

21 Jan 5min

Populært innen Politikk og nyheter

giver-og-gjengen-vg
aftenpodden
aftenpodden-usa
forklart
popradet
fotballpodden-2
stopp-verden
nokon-ma-ga
rss-espen-lee-usensurert
det-store-bildet
dine-penger-pengeradet
lydartikler-fra-aftenposten
rss-gukild-johaug
hanna-de-heldige
rss-ness
aftenbla-bla
chit-chat-med-helle
rss-dannet-uten-piano
e24-podden
frokostshowet-pa-p5